316 related articles for article (PubMed ID: 37840070)
1. Neuroimmune Connectomes in the Gut and Their Implications in Parkinson's Disease.
Thomasi B; Valdetaro L; Gulbransen B; Tavares-Gomes AL
Mol Neurobiol; 2024 Apr; 61(4):2081-2098. PubMed ID: 37840070
[TBL] [Abstract][Full Text] [Related]
2. Enteric glial cells: new players in Parkinson's disease?
Clairembault T; Leclair-Visonneau L; Neunlist M; Derkinderen P
Mov Disord; 2015 Apr; 30(4):494-8. PubMed ID: 25100667
[TBL] [Abstract][Full Text] [Related]
3. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
4. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
[TBL] [Abstract][Full Text] [Related]
5. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss.
Annerino DM; Arshad S; Taylor GM; Adler CH; Beach TG; Greene JG
Acta Neuropathol; 2012 Nov; 124(5):665-80. PubMed ID: 22941241
[TBL] [Abstract][Full Text] [Related]
7. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson's Disease.
Montalbán-Rodríguez A; Abalo R; López-Gómez L
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279293
[TBL] [Abstract][Full Text] [Related]
8. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
9. The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration.
Natale G; Ryskalin L; Busceti CL; Biagioni F; Fornai F
Arch Ital Biol; 2017 Sep; 155(3):118-130. PubMed ID: 29220864
[TBL] [Abstract][Full Text] [Related]
10. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
[TBL] [Abstract][Full Text] [Related]
11. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
Anis E; Xie A; Brundin L; Brundin P
Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
[TBL] [Abstract][Full Text] [Related]
12. Rotenone and elevated extracellular potassium concentration induce cell-specific fibrillation of α-synuclein in axons of cholinergic enteric neurons in the guinea-pig ileum.
Sharrad DF; Chen BN; Gai WP; Vaikath N; El-Agnaf OM; Brookes SJ
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27997067
[TBL] [Abstract][Full Text] [Related]
13. Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease.
Benvenuti L; D'Antongiovanni V; Pellegrini C; Antonioli L; Bernardini N; Blandizzi C; Fornai M
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276665
[TBL] [Abstract][Full Text] [Related]
14. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
[TBL] [Abstract][Full Text] [Related]
15. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
16. Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson's Disease.
Williams GP; Schonhoff AM; Sette A; Lindestam Arlehamn CS
J Parkinsons Dis; 2022; 12(s1):S129-S136. PubMed ID: 35754290
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
18. Enteric glia as a player of gut-brain interactions during Parkinson's disease.
Thomasi B; Valdetaro L; Ricciardi MC; Gonçalves de Carvalho M; Fialho Tavares I; Tavares-Gomes AL
Front Neurosci; 2023; 17():1281710. PubMed ID: 38027511
[TBL] [Abstract][Full Text] [Related]
19. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
20. Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.
Del Tredici K; Braak H
Neuropathol Appl Neurobiol; 2016 Feb; 42(1):33-50. PubMed ID: 26662475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
